Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate

Publish date:: October 20, 2020

Key clinical point: Older age, relapsed/refractory (r/r) disease in lymphoma patients tied to an increased death rate from COVID-19.

Major finding: Patients younger than age 70 years, without r/r lymphoma had an 88% 30-day overall survival, comparable to the general population.

Study details: Retrospective database of all 89 adult patients with lymphoma who were hospitalized for COVID-19.

Disclosures: The study was unsponsored. Several of the authors reported financial relationships with a number of biotechnology and pharmaceutical companies.

Citation:

Lamurea S et al. EClinicalMedicine. 2020 Oct 12. doi: 10.1016/j.eclinm.2020.100549.

This Week's Must Reads

Higher dose maximizes effects of magnesium sulfate for obese women,

Microplastics permeate human placentas,

One in five gestational carriers do not meet ASRM criteria,

Gender surgical outcomes differ following puberty suppression,

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Must Reads in COVID-19 Updates

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Obesity, hypoxia predict severity in children with COVID-19,

One-third of critical illness survivors emerge from ICU with functional deterioration,

COVID-19 burdens follow patients after discharge,

Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?,